Cardalis chewable tablets for dogs 2.5/20 mg 30 Tab
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
CARDALIS® contains two active ingredients, benazepril hydrochloride and spironolactone, in a ratio of 1:8 respectively. CARDALIS® is supplied as brown oblong half-scored flavored chewable tablets. Benazepril belongs to the angiotensin-converting enzyme (ACE) inhibitor class of drugs. Spironolactone, and its active metabolites, act as specific aldosterone receptor antagonists. Both ACE inhibitors and aldosterone receptor antagonists act on the renin-angiotensin-aldosterone system.
Product Details
| DIN (Drug Identification Number) | 02542080 |
| Active Ingredients | two active ingredients, benazepril hydrochloride and spironolactone, in a ratio of 1:8 respectively |
| Approved For | Dog |
| Therapeutic Use | Renin angiotensine system agent |
| Form | Tablet |
| Route of Administration | Oral |
| Strength / Concentration | 2.5/20 mg mg |
| Pack Size | 30 Tab |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Ceva |
|---|---|
| DIN | 2542080 |
| Active Ingredient | two active ingredients, benazepril hydrochloride and spironolactone, in a ratio of 1:8 respectively |
| Strength | 2.5/20 mg mg |
| Pack Size | 30 Tab |
Storage & Shipping
| Shipping Weight | 0.03 kg |
|---|---|
| Storage Conditions | Ambient |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
